LAKE OSWEGO, Ore., May 3, 2012 (GLOBE NEWSWIRE) -- Galena Biopharma (Nasdaq:GALE), a biotechnology company focused on developing innovative, targeted oncology treatments addressing major unmet medical needs to advance cancer care, today announced that it has promoted Rosemary Mazanet, M.D., Ph.D., to Executive Vice President and Chief Medical Officer, effective immediately.
